BIAF
Bioaffinity Technologies
$3.03
−$0.11 (−3.5%)Oct 29, 2026
Key metrics
The numbers that frame BIAF today
- Market cap
- $1.64M
- Gross margin
- 34.6%
- EV / Sales
- 0.1
- ROIC
- -1,731.4%
- Div yield
- 0%
- Debt / equity
- 0.4
- 52wk Low
- $2.66
- 52wk High
- $80.70
Growth
Revenue and earnings trend for BIAF
RevenueNet income
See the full growth breakdown
Revenue and earnings trends, margins and the multi-year trajectory - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inCash flow & returns
Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture
Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inInsider trading
Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade
See who is buying and selling, how much, and when - updated as new filings land.
Create a free accountFree foreverNo card required
Already a member? Log inFrequently asked questions
Plain-English answers about BIAF
Is Bioaffinity Technologies a good buy?
No. Bioaffinity Technologies has poor quality and poor momentum. Both signals point to a weaker setup. Growth looks mixed. The support signal is useful, but not decisive. We think Bioaffinity Technologies is selling at a very high price.
What is the market capitalization of BIAF?
Bioaffinity Technologies's market capitalization is $1.64M.
What is the 52-week high for BIAF stock?
The 52-week high for Bioaffinity Technologies is $80.70. The current close of $3.03 is 96.2% below that high.
What is the 52-week low for BIAF stock?
The 52-week low for Bioaffinity Technologies is $2.66. The current close of $3.03 is 13.9% above that low.
Does BIAF stock pay dividends?
Bioaffinity Technologies does not currently show a dividend per share in the company data.
What is the Debt / Equity ratio for BIAF?
Bioaffinity Technologies's Debt / Equity ratio is 0.38.